| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |